An Ohio State University study found that an experimental oral drug lowers blood sugar levels and inflammation in mice with type 2 diabetes, suggesting that the medication could someday be used to treat humans with type 2 diabetes. The drug consists of a synthetic molecule that stops the biological activity of a protein called macrophage migration inhibitory factor (MIF). The researchers found that mice who have been genetically engineered not to carry the MIF protein are less likely to develop symptoms of Type 2 diabetes....